|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue (COR) | |||||
| Gross profit | |||||
| Research and development (R&D) | |||||
| Selling, general and administrative (SG&A) | |||||
| Acquisition charges | |||||
| Restructuring charges/other | |||||
| Operating profit | |||||
| Other income (expense), net (OI&E) | |||||
| Interest and debt expense | |||||
| Income before income taxes | |||||
| Provision for income taxes | |||||
| Net income | |||||
| Income allocated to RSUs | |||||
| Income allocated to common stock for diluted EPS | |||||
| Earnings per common share (EPS): | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Average shares outstanding: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) |
Loading...
